Non Surgical Hair Replacement For Men In Weston, FL
Most of the research behind non surgical hair loss treatment was run in women. The strongest trial of the platelet therapy sold for it enrolled 74 women and no men.
That does not make it useless to you. It does mean the honest version of this conversation starts with what stage you are at and what was actually tested on men.
In-person and telehealth appointments available
The phrase covers 2 products, and only 1 needs your follicles
Non surgical hair replacement is used for 2 different things.
A hair system is a hair unit bonded to the scalp with adhesive or tape. It puts hair where none grows, on a recurring service schedule, and it does nothing to what is underneath. Revive 365 does not fit or maintain them.
Medical treatment works on follicles that are still alive. StatPearls, the clinical reference hosted by the National Center for Biotechnology Information, states the drug position plainly: “Two FDA-approved treatments are available for pattern baldness: topical minoxidil and finasteride.” Injectable platelet-rich fibrin and scalp microneedling sit alongside those as treatments without FDA approval for hair loss.
The dividing line is simple. A bonded system needs a scalp. Medical treatment needs a follicle. Everything else on this page follows from which of those you still have, and that is decided by your stage.
Find your Norwood-Hamilton stage before you shop
Male pattern hair loss is graded on the Norwood-Hamilton scale. StatPearls: “The Norwood-Hamilton scale is commonly used to classify male-pattern baldness, while the Ludwig scale is used for female-pattern baldness.” It runs across 7 stages and, in shape, it describes 2 separate things happening in 2 separate places.
The temples and frontal hairline recede first for most men. That is the early part of the scale.
The vertex and mid-scalp thin separately, as a spot at the crown that widens.
The later stages are what happens when those 2 areas meet, leaving hair at the sides and back.
Almost every man reading this can point at one of those and say which bothers him. Do that now, because the 2 areas have completely different evidence behind them.
Prevalence, for scale: StatPearls puts it at “approximately 50% are affected by 50 and approximately 80% by age 70” in Caucasian men, with Caucasian men most affected, then Asian and African American men, then Native American and Inuit populations.
The mapping nobody prints
Both FDA-approved drugs are labeled for the crown. Neither is labeled for the hairline.
The over-the-counter minoxidil 5% Drug Facts label gives its use as “to regrow hair on the top of the scalp (vertex only)” and states under Do Not Use that it “is not intended for frontal baldness or receding hairline.” The finasteride label carries the indication for male pattern hair loss in men, and then states: “Efficacy in bitemporal recession has not been established.” Its registration trials enrolled men aged 18 to 41 with mild to moderate loss, 2 studying the vertex and a third the anterior mid-scalp.
Put that against the scale and the result is uncomfortable. The man at an early stage, worried about his temples, is the man the approved labels support least. The man with crown thinning is the one they were written for.
The 2-month checkpoint
The Sclafani study found something more useful than its headline number, and it is the most practical result in the whole literature.
Patients who reached more than 25% improvement by 2 months had a 100% likelihood of still being above 25% at 6 months. Patients who had not reached it by 2 months had a 16.7% likelihood (p = 0.0476).
Early response predicted late response. Absence of early response mostly predicted absence of late response.
That gives a man a decision point instead of an open-ended commitment. Measure at baseline. Measure at 2 months, under the same lighting, from the same angle, at the same part. If nothing has moved, that is information worth having at month 2 rather than month 6.
The usual caution applies and it is a real one: 15 people, one study, 2014, and 6 of the 15 were women. Treat it as a sensible way to structure a trial of the treatment, not as a rule proven at scale.
Where PRF sits with the regulators
PRF is not FDA approved for hair loss. Nothing is, apart from the 2 drugs named above.
Two precise points, because this is where marketing copy usually slips.
The FDA has never issued a position on platelet-rich fibrin by name. Its written statements in this area address a different blood preparation, and the reasoning carries across by inference rather than by anything the agency has said about PRF. So nobody should put quotation marks around an FDA position on PRF, and this page does not.
No platelet preparation device carries a hair, scalp or alopecia indication that we could identify. The centrifuges and tubes reach the market as cleared devices, and clearance is not approval: the FDA describes a 510(k) as “a premarket submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent, to a legally marketed device.” Scalp use is off-label practice of medicine. That is legal and ordinary. It is also not the same as approval, and you should be told which one you are buying.
Exosomes, offered by many clinics in this category, have no approved product at all. The FDA’s public safety notification of 6 December 2019 states: “There are currently no FDA-approved exosome products.” It was issued after serious adverse events in Nebraska patients treated with unapproved products marketed as containing exosomes, and it says clinics offering them “deceive patients with unsubstantiated claims about the potential for these products to prevent, treat or cure various diseases or conditions.”
Who this is not for
- A scalp that is smooth and reflective with nothing growing on it. Treatment that works on follicles has nothing to work with. You will be told that at the evaluation.
- A man who wants a bonded hair system fitted and maintained. Different trade, different chairs, and not something this clinic does.
- A man who wants certainty from the evidence. Read the section above again. The research is small, mostly female, and partly uncontrolled. Anyone promising you a number is going past what has been published.
- A man who needs hair this week. The minoxidil label says results may occur at 2 months and that some men need at least 4. The platelet studies measured at 2, 3 and 6 months.
- A man who wants a guaranteed result. Nobody credible offers one. The minoxidil label says it in its own words: “This product will not work for all men.”
Saying who a treatment cannot help is not a disclaimer. It is the part of the evaluation that stops you paying for something with no path to working.
Real Patient Results
Microneedling + PRF + Exosomes — After 2 Sessions
Results vary by individual and treatment plan
Frequently Asked Questions
Was any of this research done on men?
Partly, and less than you would assume. The only randomized trial of injectable PRF for hair loss enrolled 74 women with female pattern hair loss and no men. The one study with a male majority had 9 men out of 15, was published in 2014, and its 6-month density result did not reach statistical significance. The largest study in androgenetic alopecia patients does not report how many participants were men.
Will treatment help my receding hairline?
The approved drugs are not labeled for it. The minoxidil 5% label states it “is not intended for frontal baldness or receding hairline,” and the finasteride label states that “efficacy in bitemporal recession has not been established.” Both are labeled for the top of the scalp. Your stage decides how much that matters, which is why grading comes before recommending.
How do I know if it is working, and when?
Photograph the same area, same light, same angle, same part, at baseline and at 2 months. The Sclafani study found that men and women who passed 25% improvement by 2 months stayed above it at 6, while those who had not mostly did not get there. It is 1 small study, so treat it as a sensible checkpoint rather than a guarantee.
Is PRF FDA approved for hair loss?
No. Only topical minoxidil and finasteride are FDA approved for pattern hair loss. The equipment used to prepare PRF reaches the market as cleared devices, and no platelet preparation device we could identify carries an indication for hair, scalp or alopecia. Scalp use is off-label practice of medicine, which is legal and common, and is not approval.
Does the way PRF is applied matter?
Yes, and it is worth asking anyone you consult. Every published study of PRF for hair loss injected it into the scalp. None tested it applied topically over microneedling. PRF sets within roughly 20 minutes, so the 2 routes are not interchangeable and the published results come from the injected one.
What is my Norwood stage and does it change the plan?
It changes it more than anything else you will be asked. Recession at the temples and thinning at the crown are separate processes on separate parts of the scale, with different label support and different realistic outcomes. Grading happens at the start of the evaluation, before anything is recommended.
Book a men's hair loss consultation in Weston
Bring the area that bothers you and a rough idea of when it started. You will leave with your stage graded and a straight account of what the evidence supports for a man at that stage.
